De  Servi B et al. Future Microbiology. Published on line: 29 March 2016 Aim: To evaluate whether Utipro(®), a natural product approved to prevent urinary tract infections, protects intestinal epithelial cells from Escherichia coli adherence/intracellular invasion in vitro. Materials & Methods:  Caco-2 and CacoGoblet(TM) cells were treated with Utipro (1.5 [...]

Olier M et al. Future Microbiology. Published online: 3 March 2017 Aim: Reticulated gelatin (RG), hibiscus and propolis (RGHP) is a medical device that can reduce the bacterial adherence to epithelial cultured cells and invasion by enteropathogens, thus gathering relevant properties to decrease the risk of urinary tract infections (UTIs). [...]

Salvatorelli  N et al. Urologia Internationalis. Published on line: April 8, 2016 Objective: To assess the efficacy and safety of a new medical device (MD; a capsule whose main component is a cross-linked protein) in the prevention of uncomplicated cystitis recurrences. Methods: Adult women with acute cystitis symptoms and a [...]

García-Larrosa  A et al. Clinical Microbiology 2016, 5:1 Background:  The objective of the study was to analyze the efficacy and safety of a medical device containing reticulated gelatin with hibiscus and propolis (RGHP) in the early treatment of patients with symptoms of urinary tract infection (UTI). Methods:  A double-blind, placebo-controlled [...]

Fraile B et al. Future Microbiology. Published online: 27 March 2017 Aim: To assess the properties of a medical device containing xyloglucan, propolis and hibiscus to create a bioprotective barrier to avoid the contact of uropathogenic Escherichia coli strains on cell walls in models of intestinal (CacoGoblet) and uroepithelial (RWPE-1) [...]